Global Burden of Drug‐Induced Anaphylaxis Associated With 33 Classes of Antibiotics (1968–2024): A Pharmacovigilance Analysis
Clinical & Experimental Allergy · 2025
DOI: 10.1111/cea.70121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical & Experimental Allergy, 2025. Verfasst von Jaehyeong Cho und 13 weiteren Autor:innen. Beteiligte Einrichtung: Center for Digital Health, Medical Science Research Institute, Kyung Hee University College of Medicine, Seoul, South Korea. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Anaphylaxis, Pharmacovigilance. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, MSIT (Ministry of Science and ICT), Korea, under the ITRC (Information Technology Research Centre), Ministry of Science and ICT, South Korea.
Abstract (Originalsprache)
Background
Despite antibiotic‐induced anaphylaxis being a severe allergic reaction requiring immediate care, large‐scale studies examining all antibiotic subtypes remain limited. This study addresses this gap by analysing 33 antibiotic classes, along with epidemiological and regional variations.
Methods
This study utilised the world's largest pharmacovigilance database, with over 35 million individual case safety reports from 140 countries. The study employed a two‐step approach: first, the antibiotics were grouped into 10 categories according to their third‐level ATC codes and their frequencies were collectively analysed. These categories comprised tetracyclines (J01A), amphenicols (J01B), beta‐lactam antibacterial penicillins (J01C), other beta‐lactam antibacterials (J01D), sulfonamides and trimethoprim (J01E), macrolides, lincosamides and streptogramins (J01F), aminoglycoside antibacterials (J01G), quinolone antibacterials (J01M), combinations of antibacterials (J01R) and other antibacterials (J01X). Second, a more detailed analysis was performed at the fourth level of the ATC codes for the antibiotics categorised at the third level, focusing on 33 individual antibiotics. For statistical analysis, disproportionality metrics, including the information component (IC) with IC 025 and reporting odds ratio (ROR) with 95% CI, were used to classify and analyse the risk of anaphylaxis related to these drugs.
Results
A total of 144,820 reports were identified as antibiotic‐induced anaphylaxis. All antibiotics showed significant signal detection for anaphylaxis (ROR, 20.50 [95% CI, 20.37–20.63]; IC, 3.77 [IC 025 , 3.76]) across all age groups and sexes. The following three antibiotics took the most proportion of the reports: penicillins (39,696/144,820 [27.4%]; ROR, 18.82 [95% CI, 18.62–19.01]; IC, 4.04 [IC 025 , 4.02]), other beta‐lactam antibiotics (63,644/144,820 [43.9%]; 27.59 [27.35–27.83]; 4.48 [4.46]) and quinolones (20,303/144,820 [14.0%]; 13.40 [13.21–13.60]; 3.63 [3.61]). The median time‐to‐onset was 1 day (interquantile range, 1–1), with most r recovered (96.09%) and the fatality rate accounting for 1.23%.
Conclusion
Although our findings do not permit causal inference, the analysis highlights the need for standardised grading systems, patient‐specific risk factors and long‐term outcome studies to improve prevention and management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Digital Health, Medical Science Research Institute, Kyung Hee University College of Medicine, Seoul, South Korea.
- Department of Medicine, CHA University School of Medicine, Seongnam, South Korea.
- Department of Precision Medicine, Kyung Hee University College of Medicine, Seoul, South Korea.
- Department of Regulatory Science, Kyung Hee University, Seoul, South Korea.
- Department of Medicine, Kyung Hee University College of Medicine, Seoul, South Korea.
- Department of Neurology, Kyung Hee University Medical Center, Kyung Hee University College of Medicine, Seoul, South Korea.
ORCID-Profile: Jaeyu Park, Hyesu Jo, Kyeongeun Kim, Yerin Hwang, Michael Miligkos, Dong Keon Yon
Förderung
- National Research Foundation of Korea
- MSIT (Ministry of Science and ICT), Korea, under the ITRC (Information Technology Research Centre)
- Ministry of Science and ICT, South Korea
Zitieren
APA
Cho, J., Oh, J., Park, J., Jo, H., Kim, T. H., Kim, H., Yim, Y., Park, S., Kim, K., Woo, H. G., Hwang, Y., Miligkos, M., Yon, D. K., & Papadopoulos, N. G. (2025). Global Burden of Drug‐Induced Anaphylaxis Associated With 33 Classes of Antibiotics (1968–2024): A Pharmacovigilance Analysis. Clinical & Experimental Allergy. https://doi.org/10.1111/cea.70121
Vancouver
Cho J, Oh J, Park J, Jo H, Kim TH, Kim H, et al. Global Burden of Drug‐Induced Anaphylaxis Associated With 33 Classes of Antibiotics (1968–2024): A Pharmacovigilance Analysis. Clinical & Experimental Allergy. 2025. doi:10.1111/cea.70121
BibTeX
@article{Cho2025,
author = {Cho, Jaehyeong and Oh, Jeongseon and Park, Jaeyu and Jo, Hyesu and Kim, Tae Hyeon and Kim, Hyunjee and Yim, Yesol and Park, Seoyoung and Kim, Kyeongeun and Woo, Ho Geol and Hwang, Yerin and Miligkos, Michael and Yon, Dong Keon and Papadopoulos, Nikolaos G},
title = {Global Burden of Drug‐Induced Anaphylaxis Associated With 33 Classes of Antibiotics (1968–2024): A Pharmacovigilance Analysis},
journal = {Clinical & Experimental Allergy},
year = {2025},
doi = {10.1111/cea.70121}
}
EUVIMED